Go to content
UR Home

A single-arm phase II Austrian/German multicenter trial on continuous daily sunitinib in primary glioblastoma at first recurrence (SURGE 01-07)

Hutterer, Markus, Nowosielski, Martha, Haybaeck, Johannes, Embacher, Sabine, Stockhammer, Florian, Gotwald, Thaddäus, Holzner, Bernhard, Capper, David, Preusser, Matthias, Marosi, Christine, Oberndorfer, Stefan, Moik, Martin, Buchroithner, Johanna, Seiz, Marcel, Tuettenberg, Jochen, Herrlinger, Ulrich, Wick, Antje, Vajkoczy, Peter and Stockhammer, Günther (2014) A single-arm phase II Austrian/German multicenter trial on continuous daily sunitinib in primary glioblastoma at first recurrence (SURGE 01-07). Neuro-Oncology 16 (1), pp. 92-102.

Full text not available from this repository.

at publisher (via DOI)


Abstract

Background: Due to the redundancy of molecular pathways simultaneously involved in glioblastoma growth and angiogenesis, therapeutic approaches intervening at multiple levels seem particularly appealing. Methods: This prospective, multicenter, single-arm phase II trial was designed to evaluate the antitumor activity of sunitinib, an oral small-molecule inhibitor of several receptor tyrosine ...

plus


Export bibliographical data



Item type:Article
Date:2014
Institutions:Medicine > Zentren des Universitätsklinikums Regensburg > Zentrum für Hirntumore (ZHT)
Identification Number:
ValueType
10.1093/neuonc/not161DOI
Keywords:antitumor activity and safety, glioblastoma, molecular markers, quality of life, sunitinib
Dewey Decimal Classification:600 Technology > 610 Medical sciences Medicine
Status:Published
Refereed:Yes, this version has been refereed
Created at the University of Regensburg:Unknown
Item ID:29406
Owner only: item control page
  1. Homepage UR

University Library

Publication Server

Contact:

Publishing: oa@ur.de

Dissertations: dissertationen@ur.de

Research data: daten@ur.de

Contact persons